Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population

INTRODUCTION: In Australia, there is an unmet need for improved treatments for rheumatoid arthritis (RA). Tofacitinib is an oral Janus kinase inhibitor for the treatment of RA. To provide an overview of key study outcomes for tofacitinib in Australian patients, we analyzed the efficacy and safety of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Rheumatol Ther
Autors principals: Hall, Stephen, Nash, Peter, Rischmueller, Maureen, Bossingham, David, Bird, Paul, Cook, Nicola, Witcombe, David, Soma, Koshika, Kwok, Kenneth, Thirunavukkarasu, Krishan
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251845/
https://ncbi.nlm.nih.gov/pubmed/29949132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-018-0118-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars